BETHNEY SEIFERT: Open Payments
NPI 1316480817 · BANGOR, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,874 in 94 payments from 12 companies in 2025. Trend: 2023 $1,976 · 2024 $2,544 · 2025 $1,874
Food & beverage: $1,874
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $430 |
| Vanda Pharmaceuticals Inc. | 23 | $406 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $310 |
| Otsuka America Pharmaceutical, Inc. | 8 | $200 |
| Supernus Pharmaceuticals, Inc. | 3 | $139 |
| Biogen, Inc. | 1 | $115 |
| Tris Pharma Inc | 5 | $103 |
| Alkermes, Inc. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 1 | $38 |
| Almatica Pharma LLC | 1 | $29 |
Products named: VRAYLAR, FANAPT, CAPLYTA, Qelbree, TYSABRI, REXULTI, Dyanavel XR, HETLIOZ.
Industry payments across ME — which companies pay providers there.
